Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Allergic Bronchopulmonary Aspergillosis
Interventions
DRUG

Prednisolone

Prednisolone 0.5 mg/kg/day for 4 weeks; 0.25 mg/kg/day for 4 weeks; 0.125 mg/kg/day for 4 weeks. Then taper by 5 mg every 4 weeks and discontinue. Patients will also receive inhaled formoterol/fluticasone (6/125 mcg) 1 puff BD and as needed as per the SMART approach for control of asthma

DRUG

Voriconazole

Voriconazole 200 mg BD for 4 months. Patients will also receive inhaled formoterol/fluticasone (6/125 mcg) 1 puff BD and as needed as per the SMART approach for control of asthma

Trial Locations (1)

160012

Postgraduate Institute of Medical Education and Research, Chandigarh

All Listed Sponsors
collaborator

Cipla Ltd.

INDUSTRY

lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT01621321 - Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis | Biotech Hunter | Biotech Hunter